UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 3 | March 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 7 Issue 11
November-2020
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2011179


Registration ID:
303524

Page Number

327-339

Share This Article


Jetir RMS

Title

Formulation development and characterization of Chitosan nanoparticles bearing Rizatriptan Benzoate for intranasal delivery

Abstract

The present investigation was aimed to formulate and characterize chitosan nanoparticles (CS-NPs) loaded with Rizatriptan Benzoate (RIZ) for intranasal administration for brain targeting. The NPs were prepared using inotropic gelation method. Optimization of the process and formulation parameters was done using the Box-Behnken design (BBD). The optimized batch having the concentrations of chitosan and sodium tri-polyphosphate were found to be 0.4 %w/v and 0.3 %w/v respectively while the Zeta potential and Z-average size were also found to be +49 mV and 201 nm with poly dispersity index of 0.2 respectively. Drug entrapment efficiency (% EE) and drug loading (% DL) were of 63.5±1.61% and 17.3±1.38 % w/w respectively. Moreover, improved in-vitro and ex-vivo release profile of CS-NPs were observed in comparison to drug solution. In a nutshell, the developed formulation holds a great promise in overcoming the limitation associated with currently marketed RIZ formulations and illustrates the potential use of CS-NPs to administer the drug by nasal route for brain targeting.

Key Words

Chitosan nanoparticles (CS-NPs), Ionotropic gelation, Rizatriptan benzoate, Brain delivery, Migraine

Cite This Article

"Formulation development and characterization of Chitosan nanoparticles bearing Rizatriptan Benzoate for intranasal delivery", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 11, page no.327-339, November-2020, Available :http://www.jetir.org/papers/JETIR2011179.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Formulation development and characterization of Chitosan nanoparticles bearing Rizatriptan Benzoate for intranasal delivery", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 11, page no. pp327-339, November-2020, Available at : http://www.jetir.org/papers/JETIR2011179.pdf

Publication Details

Published Paper ID: JETIR2011179
Registration ID: 303524
Published In: Volume 7 | Issue 11 | Year November-2020
DOI (Digital Object Identifier):
Page No: 327-339
Country: Patan, Gujarat, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003033

Print This Page

Current Call For Paper

Jetir RMS